Answers are grounded in this paper and cite their sources.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease. Simple and affordable surrogates of insulin resistance may aid in identifying at-risk individuals. In this study, we examined the association between the triglyceride-glucose (TyG) index and TyG-based anthropometric composites (TyG-BMI, TyG-WC, and TyG-WHtR) and development of probable MASLD after 10 years. We set up the main outcome based on the Hepatic Steatosis Index (HSI > 36) and sensitivity outcome based on the Fatty Liver Index (FLI ≥ 60). During the follow-up of 10 years, probable MASLD developed in 53.9% of participants based on HSI and 37.5% based on FLI. Each 1-SD increment of TyG independently raised the risk of developing probable MASLD. Moreover, the third tertile of TyG was also associated with elevated odds of probable MASLD compared to the first tertile (OR = 1.60 for HSI and OR = 2.20 for FLI). Discrimination capacity of TyG alone was modest (AUC = 0.59 for HSI and AUC = 0.68 for FLI), while composite indices showed larger AUC (0.73 to 0.84 for HSI and 0.79 to 0.85 for FLI), the highest for TyG-BMI. However, since BMI and WC are included in HSI and FLI, adjusting for the related anthropometric variable substantially reduced the associations of the composite indices.
No takes yet. Share an insight, caveat, or question.
Kondori et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: